Edgewood, Kentucky : Phone: (859) 331-4159
RESEARCH
mild Postmarket Clinical Studies

Working with a scientific advisory board composed of clinical experts in pain medicine and neurosurgery, the company has developed a comprehensive clinical program to validate the safety and efficacy of the devices and procedure. This program includes several postmarket clinical studies at leading pain centers across the coun

mild Postmarket Clinical Studies

Completed

Ongoing
  • MiDAS II: 50-patient, open label, single-arm, multi-center, prospective IRB-approved study; enrollment completed
    See press release on six-week study findings
    See clinical poster on six-week study findings
  • ESI-I Trial: 40-patient, single-site, randomized, double-blind, prospective, IRB-approved study comparing mild and epidural steroid injections; enrollment completed
  • MiDAS ECO: 200-patient, multi-site, randomized, IRB-approved study comparing mild and epidural steroid injections; future enrollment
  • Prospective Patient Series: 50-patient, single-site, open label, single-arm, prospective, IRB-approved study; now enrolling

Fully detailed study methodologies are available upon request.

*Cleared by the U.S. Food and Drug Administration for lumbar decompression, Vertos mild is designed to treat lumbar spinal stenosis (LSS).


Ongoing Clinical Research

Clinical Research Experience

Principal Investigator A Product Surveillance Trial sponsored by XXXXXXX- A non-randomized active prospective post-marketsurveillance trial to determine the continuing evaluation and periodic reporting of safety andeffectiveness of market-released products for their intended use.

Principal Investigator XXX-XXXX A Randomized, Double-blind, Double-dummy, Placebo-controlled, Active-controlled, Parallel-group, Multicenter Trial of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess the Analgesic Efficacy (Compared to Placebo) and the Management of Opioid-induced Constipation (Compared to Oxycodone Controlled-release Tablets (OXY) in Opioid-experienced Subjects with Moderate to Severe Chronic Low Back Pain and a History of Opioid-induced Constipation who Require Around-the-clock Opioid Therapy.

Sub-Investigator XXX-XXX Phase 3, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Flexible Dose Titration, Efficacy and Safety Study of XXX-XXX in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder With Inadequate Response to Prospective Treatment With an Antidepressant.

Sub-Investigator XXX-XXX A Phase 3, Open-label, Multicenter, 12-month Extension Safety and Tolerability Study of XXX-XXX in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder With Residual Symptoms or Inadequate Response Following Treatment With an Antidepressant


OTRIMED Clinical Research




Otrimed is an independent research site dedicated to conducting high quality clinical trials focused on pain management, achieved through ensuring patient safety and the execution of quality research by our experienced staff. Our integrity, well organized project management and detailed data collection, complemented by our dedication to recruitment and retention ensures expected timelines are met or exceeded. Otrimed is an affiliate of Advanced Pain Treatment Center .

Referring A Patient
Appointments by Phone
Calls may be monitored or recorded for quality purposes.

Edgewood, Kentucky
162 Barnwood Drive
Edgewood, KY 41017
(859) 331-4159 • Fax (859) 331-4163

Contact Us